233 related articles for article (PubMed ID: 14614054)
1. Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.
Tzankov A; Zimpfer A; Pehrs AC; Lugli A; Went P; Maurer R; Pileri S; Dirnhofer S
Mod Pathol; 2003 Nov; 16(11):1141-7. PubMed ID: 14614054
[TBL] [Abstract][Full Text] [Related]
2. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
[TBL] [Abstract][Full Text] [Related]
3. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
[TBL] [Abstract][Full Text] [Related]
4. Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces.
Huang Q; Wilczynski SP; Chang KL; Weiss LM
Am J Clin Pathol; 2006 Aug; 126(2):222-9. PubMed ID: 16891197
[TBL] [Abstract][Full Text] [Related]
5. BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma.
Hoeller S; Zihler D; Zlobec I; Obermann EC; Pileri SA; Dirnhofer S; Tzankov A
Histopathology; 2010 Jan; 56(2):217-28. PubMed ID: 20102401
[TBL] [Abstract][Full Text] [Related]
6. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall.
Yao X; Teruya-Feldstein J; Raffeld M; Sorbara L; Jaffe ES
Mod Pathol; 2001 Feb; 14(2):105-10. PubMed ID: 11235901
[TBL] [Abstract][Full Text] [Related]
7. Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas.
Kanavaros P; Gaulard P; Charlotte F; Martin N; Ducos C; Lebezu M; Mason DY
Am J Pathol; 1995 Mar; 146(3):735-41. PubMed ID: 7887454
[TBL] [Abstract][Full Text] [Related]
8. Classical Hodgkin's disease. Clinical impact of the immunophenotype.
von Wasielewski R; Mengel M; Fischer R; Hansmann ML; Hübner K; Franklin J; Tesch H; Paulus U; Werner M; Diehl V; Georgii A
Am J Pathol; 1997 Oct; 151(4):1123-30. PubMed ID: 9327746
[TBL] [Abstract][Full Text] [Related]
9. Extranodal marginal zone B cell lymphomas of the uvea: an analysis of 13 cases.
Coupland SE; Foss HD; Hidayat AA; Cockerham GC; Hummel M; Stein H
J Pathol; 2002 Jul; 197(3):333-40. PubMed ID: 12115879
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases.
Tzankov A; Krugmann J; Fend F; Fischhofer M; Greil R; Dirnhofer S
Clin Cancer Res; 2003 Apr; 9(4):1381-6. PubMed ID: 12684408
[TBL] [Abstract][Full Text] [Related]
11. High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1.
Tzankov A; Zimpfer A; Lugli A; Krugmann J; Went P; Schraml P; Maurer R; Ascani S; Pileri S; Geley S; Dirnhofer S
J Pathol; 2003 Feb; 199(2):201-7. PubMed ID: 12533833
[TBL] [Abstract][Full Text] [Related]
12. Large B-cell lymphoma with Hodgkin's features.
García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
Khalidi HS; Singleton TP; Weiss SW
Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
[TBL] [Abstract][Full Text] [Related]
14. Plasmablastic lymphoma: a clinicopathologic correlation.
Folk GS; Abbondanzo SL; Childers EL; Foss RD
Ann Diagn Pathol; 2006 Feb; 10(1):8-12. PubMed ID: 16414538
[TBL] [Abstract][Full Text] [Related]
15. Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia.
Atkins SR; Turesson C; Myers JL; Tazelaar HD; Ryu JH; Matteson EL; Bongartz T
Arthritis Rheum; 2006 Feb; 54(2):635-41. PubMed ID: 16447242
[TBL] [Abstract][Full Text] [Related]
16. B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray.
Tumwine LK; Campidelli C; Righi S; Neda S; Byarugaba W; Pileri SA
Hum Pathol; 2008 Jun; 39(6):817-23. PubMed ID: 18436278
[TBL] [Abstract][Full Text] [Related]
17. B cells in classical Hodgkin lymphoma are important actors rather than bystanders in the local immune reaction.
Tudor CS; Distel LV; Eckhardt J; Hartmann A; Niedobitek G; Buettner M
Hum Pathol; 2013 Nov; 44(11):2475-86. PubMed ID: 24029709
[TBL] [Abstract][Full Text] [Related]
18. CD20 positivity in classical Hodgkin's lymphoma: Diagnostic challenge or targeting opportunity.
Barakzai MA; Pervez S
Indian J Pathol Microbiol; 2009; 52(1):6-9. PubMed ID: 19136769
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma.
Pilozzi E; Pulford K; Jones M; Müller-Hermelink HK; Falini B; Ralfkiaer E; Pileri S; Pezzella F; De Wolf-Peeters C; Arber D; Stein H; Mason D; Gatter K
J Pathol; 1998 Oct; 186(2):140-3. PubMed ID: 9924428
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of imprint cytology in the assessment of Hodgkin's disease in Japan.
Funamoto Y; Nagai M; Haba R; Ishikawa M; Kishida F; Kohno K; Matsunaga T; Kushida Y; Kobayashi S
Diagn Cytopathol; 2005 Jul; 33(1):20-5. PubMed ID: 15945083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
